**7. References**


New Molecular Biomarkers Candidates for the Development of Multiparametric

Vol.15, No.1, (February 1995), pp. 64-69, ISSN 0272-8087

No.1, (January 2000), pp. 78–84, ISSN 0168-8278

No.5, (December 2003), pp. 419-436, ISSN 0312-5963

2002), pp. 535-538, ISSN 1061-186X

23.01.2007, Available from

0021-9258

0893-3952

Platforms for Hepatocellular Carcinoma Diagnosis, Prognosis and Personalised Therapy 93

Descamps, S., Lebourhis, X., Delehedde, M., Boilly, B. & Hondermarck, H. (1998), Nerve

Di Bisceglie AM. (1995). Hepatitis C and hepatocellular carcinoma. *Seminars in Liver Disease*,

Djakiew, D., Delsite, R., Pflug, B., Wrathall, J., Lynch, J.H. & Onoda, M. (1991). Regulation of

Fields, A.C., Cotsonis, G., Sexton, D., Santoianni, R. & Cohen, C. (2004). Survivin expression

Gabizon, A.A. (2002). Liposomal drug carrier systems in cancer chemotherapy: current

Gabizon, A., Shmeeda, H. & Barenholz, Y. (2003). Pharmacokinetics of pegylated liposomal

Gonsalves, F.C., Klein, K., Carson, B.B., Katz, S., Ekas, L.A., Evans, S., Nagourney, R.,

Grizzi, F., Franceschini, B., Hamrick, C., Frezza, E.E., Cobos, E. & Chiriva-Internati, M.

Huang, G.T., Lee, H.S., Chen, C.H., Sheu, J.C., Chiou, L.L., Chen, D.S. (1999) Correlation of

*America*, Vol.108, No.15, (April 2011), pp. 5954-5963, ISSN 0027-8424 Goodison, S., Urquidi, V. & Tarin, D. (1999). CD44 cell adhesion molecules. *Molecular* 

*pathology*, Vol.52, No.4, (August 1999), pp. 189-196, ISSN 1366-8714

http://www.translational-medicine.com/content/5/1/3

growth factor is mitogenic for cancerous but not normal human breast epithelial cells. *Journal Biological Chemistry*, Vol.273, No.27, (July 1998), pp. 16659-16662, ISSN

growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate. *Cancer Research*, Vol.51, No.12, (June 1991), pp. 3304-3310, ISSN 0008-5472 Endo, K. & Terada, T. (2000) Protein expression of CD44 (standard and variant isoforms) in

hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. *Journal of Hepatology*, Vol.32,

in hepatocellular carcinoma: correlation, with proliferation, prognostic parameters, and outcome. *Modern Pathology*, Vol.17, No.11, (November 2004), pp. 1378–85, ISSN

status and future prospects. *Journal of Drug Targeting*, Vol.10, No.7, (November

Doxorubicin: review of animal and human studies. *Clinical Pharmacokinetics*, Vol.42,

Cardozo, T., Brown, A.M. & Dasgupta, R. (2011). An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. *Proceedings of the National Academy of Sciences of the United States of* 

(January 2007). Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. In: *Journal of Translational Medicine*,

E-cadherin expression and recurrence of hepatocellular carcinoma. *Hepatogastroenterology*, Vol.46, No.27, (June 1999), pp. 1923–1927, ISSN 0172-6390 Huang, S.M., Mishina, Y.M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G.A., Charlat, O.,

Wiellette, E., Zhang, Y., Wiessner, S., Hild, M., Shi, X., Wilson, C.J., Mickanin, C., Myer, V., Fazal, A., Tomlinson, R., Serluca, F., Shao, W., Cheng, H., Shultz, M., Rau, C., Schirle, M., Schlegl, J., Ghidelli, S., Fawell, S., Lu, C., Curtis, D., Kirschner, M.W., Lengauer, C., Finan, P.M., Tallarico, J.A., Bouwmeester, T., Porter, J.A., Bauer, A. & Cong, F. (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. *Nature*, Vol. 461, No.7264, (October 2009), pp. 614–620, ISSN 0028-0836 Ito, N., Kawata, S., Tamura, S., Takaishi, K., Yabuuchi, I., Matsuda, Y., Nishioka, M. & Tarui,

S. (1990). Expression of transforming growth factor b1 mRNA in human


Bosch, F.X., Ribes, J., Diaz, M. & Cleries, R. (2004). Primary liver cancer: worldwide

Breuhan, K., Longerich, T. & Schirmacher, P. (2006). Dysregulation of growth factor

Brown, L.F., Berse, B., Jackman, R.W., Tognazzi, K., Manseau, E.J., Senger, D.R. & Dvorak,

Bugianesi, E. (2005). Review article: steatosis, the metabolic syndrome and cancer.

Charrad, R.S., Gadhoum, Z., Qi, J., Glachant, A., Allouche, M., Jasmin, C., Chomienne, C. &

Chen, B., Dodge, M.E., Tang, W., Lu, J., Ma, Z., Fan, C.W., Wei, S., Hao, W., Kilgore, J.,

Chen M, Wang, J., Lu, J., Bond, M.C., Ren, X.R., Lyerly, H.K., Barak, L.S. & Chen, W. (2009b)

Chuang, S.C., La Vecchia, C. & Boffetta, P. (2009). Liver cancer: descriptive epidemiology

Colnot, S., Decaens, T., Niwa-Kawakita, M., Godard, C., Hamard, G., Kahn, A., Giovannini,

Colombo, M. (2003). Malignant neoplasm of the liver. In: *Schiff's Disease of the Liver*, E.R.

Daveau, M., Scotte, M., Francois, A., Coulouarn, C., Ros, G., Tallet, Y., Hiron, M., Hellot,

Vol.48, No.43, (November 2009), pp. 10267–10274, ISSN 0006-2960

*Research*, Vol.53, No.19, (October 1993), pp. 4727–4735, ISSN 0008-5472 Buendia, M.A. (2000). Genetics of hepatocellular carcinoma. *Seminars in Cancer Biology*,

Vol.10, No.3, (June 2000), pp. 185–200, ISSN 1044-579X

No.1, (January 2002), pp. 290–299, ISSN 0006-4971

(December 2009), pp. 9-14, ISSN 0304-3835

1377-404, ISBN 978-0-7817-6040-9, Philadelphia

No.15, (July 1998), pp. 8847–8851, ISSN 0027-8424

pp. 17216–17221, ISSN 0027-8424

pp. S5–S16, ISSN 0016-5085

pp. 3787–3800, ISSN 0950-9232

43, ISSN 0269-2813

ISSN 1552-4450

incidence and trends. *Gastroenterology*, Vol.127, No. 5 Suppl.1, (November 2004),

signalling in human hepatocellular carcinoma. *Oncogene*, Vol.25, No.27, (June 2006),

H.F. (1993). Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinoma of gastrointestinal tract. *Cancer*

*Alimentary Pharmacology & Therapeutics*, Vol.22, Suppl 2, (November 2005), pp. 40–

Smadja-Joffe, F. (2002). Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. *Blood*, Vol.99,

Williams, N.S., Roth, M.G., Amatruda, J.F., Chen, C. & Lum, L. (2009a) Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. *Nature Chemical Biology*, Vol.5, No.2, (February 2009), pp., 100–107,

The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling. *Biochemistry*,

and risk factors other than HBV and HCV infection. *Cancer Letters*, Vol.286, No.1,

M. & Perret, C. (2004). Liver-targeted disruption of APC in mice activates β-catenin signaling and leads to hepatocellular carcinomas. *Proceedings of the National Academy of Sciences of the United States of America*, Vol.101, No.49, (December 2004),

Schiff, M.F. Sorrell & W.C. Maddrey, (Eds.), Lippincott William & Wilkins, pp.

M.F. & Salier, J.P. (2003). Hepatocyte growth factor, transforming growth factor a, and their receptors as combined markers of prognosis in hepatocellular carcinoma. *Molecular Carcinogenesis*, Vol.36, No.3, (March 2003), pp. 130–41, ISSN 0899-1987 De La, C.A., Romagnolo, B., Billuart, P., Renard, C.A., Buendia, M.A., Soubrane, O., Fabre,

M., Chelly, J., Beldjord, C., Kahn, A. & Perret, C. (1998). Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. *Proceedings of the National Academy of Sciences of the United States of America*, Vol.95,

	- http://www.translational-medicine.com/content/5/1/3

New Molecular Biomarkers Candidates for the Development of Multiparametric

755–763, ISSN 1043-1802

1547-3287

2000), pp. 208–218, ISSN 1525-7797

2004), pp. 653-667, ISSN 1568-0096

pp. 2060–2069, ISSN 0002-9270

211–231, ISSN 1567-2379

1078-0432

2010), pp. 23–33, ISSN 1083-7159

No.7, (July 2009), pp. 679–695. ISSN 0946-2716

No.7, (April 1996), pp. 931–934, ISSN 0007-0920

No.8, (April 1999), pp. 4540-4545, ISSN 0027-8424

Platforms for Hepatocellular Carcinoma Diagnosis, Prognosis and Personalised Therapy 95

Luo, Y. & Prestwich, G. D. (1999). Synthesis and selective cytotoxicity of a hyaluronic acid-

Luo, Y., Ziebell, M. R. & Prestwich, G. D. (2000). A hyaluronic acid-taxol antitumor

Luo, Y., Bernshaw, N. J., Lu, Z. R., Kopecek, J. & Prestwich, G. D. (2002). Targeted delivery

Liu, L.L., Fu, D., Ma, Y., Shen, X. (2011) The Power and the Promise of Liver Cancer Stem

Luu, H.H., Zhang, R., Haydon, R.C., Rayburn, E., Kang, Q., Si, W., Park, J.K., Wang, H.,

Malaguarnera, L., Rosa, M.D., Zambito, A.M., dell'Ombra, N., Marco, R.D. & Malaguarnera,

Malaguarnera, M., Di Rosa, M., Nicoletti, F. & Malaguarnera, L. (2009). Molecular

Malaguarnera, G., Giordano, M., Paladina, I., Berretta, M., Cappellani, A. & Malaguarnera,

Mann, C.D., Neal, C.P., Garcea, G., Manson, M.M., Dennison, A.R. & Berry, D.P. (2007).

Marrero, J.A., Kudo, M. & Bronowicki, J.P. (2010). The Challenge of Prognosis and Staging

Matsumura, T., Makino, R. & Mitamura, K. (2001). Frequent downregulation of E-cadherin

Mattern, J., Koomagi, R. & Volm, M. (1996). Association of vascular endothelial growth

McGregor, L.M., McCune, B.K., Graf,f J.R., McDowell, P.R., Romans, K.E., Yancopoulos,

*Sciences*, Vol.55, No.10, (October 2010), pp. 2744-55, ISSN 0163-2116

*Research*, Vol.19, No.4, (April 2002), pp. 396–402, ISSN 0724-8741

antitumor bioconjugate. *Bioconjugate Chemistry*, Vol.10, No.5, (October 1999), pp.

bioconjugate targeted to cancer cells. *Biomacromolecules*, Vol.1, No.2, (Summer

of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. *Pharmaceutical* 

Cell Markers. Stem Cells and Development, Epub ahead of print (Jun 2011), ISSN

Peng, Y., Jiang, W., and He, T.C. (2004) Wnt/beta-catenin signaling pathway as a novel cancer drug target. *Current Cancer Drug Targets*, Vol.4, No.8, (December

M. (2006). Potential role of chitotriosidase gene in non-alcoholic fatty liver disease evolution. *The American Journal of Gastroenterology*, Vol.101, No.9, (September 2006),

mechanisms involved in NAFLD progression. *Journal of Molecular Medicine*, Vol.87,

M. (2010). Serum markers of hepatocellular carcinoma. *Digestive Diseases and* 

Prognostic molecular markers in hepatocellular carcinoma: a systematic review. *European Journal of Cancer*, Vol.43, No.6, (April 2007), pp. 979-92. ISSN 0959-8049 Marhaba, R. & Zoller, M. (2004). CD44 in cancer progression: Adhesion, migration and

growth regulation. *Journal of Molecular Histology*, Vol.35, No.3, (March 2004), pp.

for Hepatocellular Carcinoma. *The Oncologist*, Vol.15, No.11 suppl 4, (November

by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. *Clinical Cancer Research*, Vol.7, No.3, (March 2001), pp. 594–599, ISSN

factor expression with intratumoural microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. *British Journal of Cancer*, Vol.73,

G.D., Ball, D.W., Baylin, S.B. & Nelkin, B.D. (1999). Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. *Proceedings of the National Academy of Sciences of the United States of America*, Vol.96,

hepatocellular carcinoma. *Japanese Journal of Cancer Research*, Vol.81, No.12, (December 1990), pp. 1202–1205, ISSN 0910-5050


Ito, Y., Takeda, T., Sakon, M., Tsujimoto, M., Higashiyama, S., Noda, K., Miyoshi, E.,

Ji, J., Yamashita, T. & Wang, XW. (January 2011). Wnt/beta-catenin signaling activates

Jothy, S. (2003). CD44 and its partners in metastasis. *Clinical and experimental metastasis*,

Kato, Y., Nakata, K., Omagari, K. Furukawa, R., Kusumoto, Y., Mori, I,, Tajima, H., Tanioka,

Koizumi, H., Morita, M., Mikami, S., Shibayama, E. & Uchikoshi, T. (1998).

Lai, T.Y., Su, C.C., Kuo, W.W., Yeh, Y.L., Ku,o W.H., Tsai, F.J., Tsai, C.H., Weng, Y.J., Huang,

Lepourcelet, M., Chen, Y.N., France, D.S., Wang, H., Crews, P., Petersen, F., Bruseo, C.,

Levi-Montalcini, R. (1987). The nerve growth factor 35 years later. *Science*, Vol.237, No.4819,

Liaw, Y.F., Tai, D.I., Chen, T.J., Chu, C.M. & Huang, M.J. (1986). Alpha-fetoprotein changes

Li, X.M., Tang, Z.Y., Qin, L.X., Zhou, J. & Sun, H.C. (1999). Serum vascular endothelial

Llovet, J.M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.F., de Oliveira, A.C.,

*Medicine*, Vol.359, No.4, (July 2008), pp. 378–390, ISSN 0028-4793

(December 1990), pp. 1202–1205, ISSN 0910-5050

No.10, (May 2001), pp. 1377–83, ISSN 0007-0920

Vol.20, No.3, (July 2003), pp. 195–201, ISSN 0262-0898

No.8, (October 1994), pp. 2234-8, ISSN 0008-543X

(September 1987), pp. 1154-1162, ISSN 0036-8075

2006), pp. 1167–1174, ISSN 1078-8956

1998), pp. 93-101, ISSN 1320-5463

ISSN 1021-335X

102. ISSN 1535-6108

511–517, ISSN 0392-9078

9543

hepatocellular carcinoma. *Japanese Journal of Cancer Research*, Vol.81, No.12,

Monden, M. & Matsuura, N. (2001). Expression and clinical significance of the erb-B receptor family in hepatocellular carcinoma. *British Journal of Cancer*, Vol.84,

microRNA-181 expression in hepatocellular carcinoma. In: *Cell and Bioscience*, 18.01.2011, Available from http://www.cellandbioscience.com/content/1/1/4 Jin, L., Hope, K.J., Zhai, Q., Smadja-JoVe, F. & Dick, J.E. (2006) Targeting of CD44 eradicates

human acute myeloid leukemic stem cells. *Nature Medicine*, Vol.12, No.10, (October

H., Yano, M. & Nagataki, S. (1994). Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer, Vol.74,

Immunohistochemical analysis of TrkA neurotrophin receptor expression in human non-neuronal carcinomas. *Pathology International*, Vol.48, No.2, (February

C.Y. & Chen, L.M. (2011). β-catenin plays a key role in metastasis of human hepatocellular carcinoma. *Oncology Reports*, Vol.26, No.2, (August 2011), pp. 415-22,

Wood, A.W. & Shivdasani, R.A. (2004) Small-molecule antagonists of the oncogenic Tcf/betacatenin protein complex. *Cancer Cell*, Vol.5, No.1, (January 2004), pp. 91–

in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma. *Liver*, Vol.6, No.3, (June 1986), pp. 133–137, ISSN 0106-

growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma. *Journal of Experimental & Clinical Cancer Research*, Vol.18, No.4, (December 1999), pp.

Santoro, A., Raoul, J.L., Forner, A., Schwartz, M., Porta, C., Zeuzem, S., Bolondi, L., Greten, T.F,. Galle, P.R., Seitz, J.F., Borbath, I., Häussinger, D., Giannaris, T., Shan, M., Moscovici, M., Voliotis, D., Bruix, J. & SHARP Investigators Study Group. (2008). Sorafenib in advanced hepatocellular carcinoma. *The New England Journal of* 


New Molecular Biomarkers Candidates for the Development of Multiparametric

(December 2004), pp. 18081–18086, ISSN 0027-8424.

2001), pp. 1378–1383, ISSN 0815-9319

1717, ISSN 0261-4189

33–45, ISSN 1471-0072

6736

ISSN 0171-5216

Platforms for Hepatocellular Carcinoma Diagnosis, Prognosis and Personalised Therapy 97

Nelson, W.J. & Nusse, R. (2004). Convergence of Wnt, -Catenin, and Cadherin Pathways. *Science*, Vol.303, No.5663, (March 2004), pp. 1483-1487, ISSN 0036-8075 Oelmann, E., Sreter, L., Schuller, I., Serve, H., Koenigsmann, M., Wiedenmann, B., Oberberg,

Oka, H., Saito, A., Ito, K., Kumada, T., Satomura, S., Kasugai, H., Osaki, Y., Seki, T., Kudo,

Okumoto, K., Hattori, E., Tamura, K., Kiso, S., Watanabe, H., Saito, K., Saito, T., Togashi, H.

*Liver International*, Vol.24, No.1, (February 2004), pp. 21–28, ISSN 1478-3223 Ono, M., Ohat, H., Ohhira, M., Sekiya, C. & Namiki, M. (1990). Measurement of

*Tumour Biology*, Vol.11, No.6, (December 1990), pp. 319–326, ISSN 1010-4283 Ozawa, M., Baribault, H. & Kemler, R. (1989). The cytoplasmic domain of the cell adhesion

Pflug, B.R., Onoda, M., Lynch, J.H. & Djakiew, D. (1992). Reduced expression of the low

Poynard, T., Bedossa, P. & Opolon, P. (1997). Natural history of liver fibrosis progression in

Qin, L.X. & Tang, Z.Y. (2004). Recent progress in predictive biomarkers for metastatic

Rasi, G., Serafino, A., Bellis, L., Lonardo, M.T., Andreola, F., Zonfrillo, M., Vennarecci, G.,

CD44-knockout mice: A different interpretation of redundancy. *Proceedings of the National Academy of Sciences of the United States of America*, Vol.101, No.52,

D., Reufi, B., Thiel, E. & Berdel, W.E. (1995). Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling. *Cancer Research*, Vol.55, No.10, (May 1995), pp. 2212-2219, ISSN 0008-5472

M., Tanaka, M. & Collaborative Hepato-Oncology Study Group of Japan. (2001). Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alphafetoprotein. *Journal of Gastroenterology and Hepatology*, Vol.16, No.12, (December

& Kawata, S. (2004). Possible contribution of circulating transforming growth factor-b1 to immunity and prognosis in unresectable hepatocellular carcinoma.

immunoreactive prothrombin precursor and vitamin-K-dependent gammacarboxylation in human hepatocellular tissues: decreased carboxylation of prothrombin precursor as a cause of des-gamma-carboxyprothrombin synthesis.

molecule uvomorulin associates with three independent proteins structurally related in different species. *The EMBO Journal*, Vol.8, No.6, (June 1989), pp. 1711-

affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. *Cancer Research*, Vol.52, No.19, (October 1992), pp. 5403-540, ISSN 0008-5472 Polakis, P. (1999). The oncogenic activation of beta-catenin. *Current Opinion in Genetics & Development*, Vol.9, No.1, (Febraury 1999), pp. 15-21, ISSN 0959-437X Ponta, H., Sherman, L. & Herrlich, P.A. (2003) CD44: from adhesion molecules to signaling

regulators. *Nature Reviews. Molecular Cell Biology*, Vol.4, No.1, (January 2003), pp.

patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. *Lancet*, Vol.349, No.9055, (March 1997), pp. 825-832, ISSN 0140-

recurrence of human hepatocellular carcinoma: a review of the literature*. Journal of Cancer Research and Clinical Oncology*, Vol.130, No.9, (September 2004), pp. 497–513,

Pierimarchi, P., Sinibaldi Vallebona, P., Ettorre, G.M., Santoro, E. & Puoti, C. (2007)


Meakin, S.O. & Shooter, E.M. (1992). The nerve growth factor family of receptors. *Trends in Neurosciences*, Vol.15, No.9, (September 1992), pp. 323-331 ISSN 0166-2236 Merle, P., de la Monte, S., Kim, M., Herrmann, M., Tanaka, S., Von Dem Bussche, A., Kew,

Micera, A., Vigneti, E., Pickholtz, D., Reich, R., Pappo, O., Bonini, S., Maquart, F.X., Aloe, L.

Micera, A., Puxeddu, I., Aloe, L. & Levi-Schaffer, F. (2003). New insights on the involvement

Miyaaki, H., Nakashima, O., Kurogi, M., Eguchi, K. & Kojiro, M. (2007). Lens culinaris

Mizejewski, G.J. (2002). Biological role of alpha-fetoprotein in cancer: prospects for

Mohanty, C., Das, M., Kanwar, J.R. & Sahoo, S.K. (2011). Receptor mediated tumor

Monga, S.P., Monga, H.K., Tan, X., Mule, K., Pediaditaki,s P. & Michalopoulos, G.K. (2003).

Moon, R.T., Kohn, A.D., De Ferrari, G.V. & Kaykas, A. (2004) WNT and beta-catenin

Mulcahy, M.F. (2005) Management of hepatocellular cancer. *Current Treatment Options in Oncology*, Vol.6, No.5, (September 2005), pp. 423–435, ISSN 1527-2729 Nair, S., Mason, A., Eason, J., Loss, G. & Perrillo, R.P. (2002). Is obesity an independent risk

Naor, D., Nedvetzki, S., Golan, I., Melnik, L. & Faitelson, Y. (2002) CD44 in cancer. *Critical* 

Nedvetzki, S., Gonen, E., Assayag, N., Reich, R., Williams, R.O., Thurmond, R.L., Huang,

Vol.127, No.4, (October 2004), pp. 1110–1122, ISSN 0016-5085

Vol.98, No.11, (May 2001), pp. 6162-6167, ISSN 0027-8424

(December 2007), pp. 962–968, ISSN 0944-1174

No.1 (January 2011), 45-58, ISSN 1567-2018

2002), pp. 709–735, ISSN 1473-7140

pp. 202–216, ISSN 0016-5085

2004), pp. 691-701, ISSN 1471-0056

2002), pp. 150-155, ISSN 0270-9139

ISSN 1040-8363

ISSN 0270-9139

M.C., Trepo, C. & Wands, J.R. (2004). Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. *Gastroenterology*,

& Levi-Schaffer, F. (2001). Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. *Proceedings of the National Academy of Sciences of the United States of America*,

of Nerve Growth Factor in allergic inflammation and fibrosis. Cytokine and Growth Factor Reviews, Vol.14, No.5, (October 2003), pp. 369-374, ISSN 1359-6101 Mise, M., Arii, S., Higashituji, H., Furutani, M, Niwano, M., Harada, T., Ishigami, S., Toda,

Y., Nakayama, H., Fukumoto, M., Fujita, J. & Imamura, M. (1996). Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. *Hepatology*, Vol.23, No.3, (March 1996), pp. 455–464,

agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma. *Journal of Gastroenterology*, Vol.42, No.12,

anticancer therapy. *Expert Review of Anticancer Therapy*, Vol.2, No.6, (December

targeting: an emerging approach for cancer therapy. *Current Drug Delivery*, Vol.8,

β-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. *Gastroenterology*, Vol.124, No.1, (January 2003),

signalling: diseases and therapies. *Nature Reviews. Genetics*, Vol.5, No.9, (September

factor for hepatocellular carcinoma in cirrhosis? *Hepatology*, Vol.36, No.1, (July

*Reviews in Clinical Laboratory Sciences*, Vol.39, No.6, (November 2002), pp. 527–579,

J.F., Neudecker, B.A., Wang, F.S., Turley, E.A. & Naor, D. (2004). RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy. *Proceedings of the National Academy of Sciences of the United States of America*, Vol.101, No.52, (December 2004), pp. 18081–18086, ISSN 0027-8424.


New Molecular Biomarkers Candidates for the Development of Multiparametric

(February 2004), pp. 109–122, ISSN 0012-1606

3004–3009. ISSN 0008-5472

2005), pp. 8093–8108, ISSN 0732-183X

1994), pp. 1045-1049, ISSN 0910-5050

1984), pp. 269-73, ISSN 0045-6039

13505–13508, ISSN 0021-9258

No.1, (February 2007), pp. 55–76, ISSN 0272-8087

0006-2979

4036

4450

0007-0920

Platforms for Hepatocellular Carcinoma Diagnosis, Prognosis and Personalised Therapy 99

Suksaweang, S., Lin, C.M., Jiang, T.X., Hughes, M.W., Widelitz, R.B. & Chuong, C.M. (2004).

Suzuki, K., Hayashi, M., Miyamaoto; Y., Yamamoto, M., Ohkawa, K., Ito, Y., Sasaki, Y.,

Takano, S., Yokosuka, O., Imazeki, F., Tagawa, M. & Omata, M. (1995). Incidence of

Thomas, M.B. & Abbruzzese, J.L. (2005). Opportunities for targeted therapies in

Thorgeirsson, S.S. & Grisham, J.W. (2002). Molecular pathogenesis of human hepatocellular

Thorne, C.A., Hanson, A.J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C.S., Jernigan,

Toi, M., Hoshina, S., Takayanagi, T. & Tominaga, T. (1994). Association of vascular

Toole, B.P. (2004). Hyaluronan: From extracellular glue to pericellular cue. Nature Reviews.

Tsai, J.F., Jeng, J.E., Chuang, L.Y., Yang, M.L., Ho, M.S., Chang, W.Y., Hsieh, M.Y., Lin, Z.Y.

Vestweber, D. & Kemler, R. (1984). Some structural and functional aspects of the cell

Villanueva, A., Newell, P., Chiang, D.Y., Friedman, S.L. & Llovet, J.M. (2007). Genomics and

Vo, N. & Goodman, R.H. (2001) CREB-binding protein and p300 in transcriptional

Cancer, Vol.4, No.7, (July 2004), pp. 528–539, ISSN 1474-175X

Morphogenesis of chicken liver: identification of localized growth zones and the role of β-catenin/Wnt in size regulation. *Developmental Biology*, Vol.266, No.1,

Yamaguchi, Y., Nakase, H., Noda, K., Enomoto, N., Arai, K., Yamada, Y., Yoshihara, H., Tujimura, T., Kawano, K., Yoshikawa, K. & Kamada, T. (1996). Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. *Cancer Research*, Vol.56, No.13, (July 1996), pp.

hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. *Hepatology*, Vol.21, No.3, (march 1995), pp. 650-655, ISSN 0270-9139 Terentiev, A.A. & Moldogazieva, N.T. (2006). Structural and functional mapping of alpha-

fetoprotein. *Biochemistry (Moscow)*, Vol.71, No.2, (February 2006), pp. 120–132, ISSN

hepatocellular carcinoma. *Journal of Clinical Oncology*, Vol.23, No.31, (November

carcinoma. *Nature Genetics*, Vol.31, No.4, (August 2002), pp. 339–346, ISSN 1061-

K.K., Meyers, K.C., Hang, B.I., Waterson, A.G., Kim, K., Melancon, B., Ghidu, V.P., Sulikowski ,G.A., LaFleur, B., Salic, A., Lee, L.A., Miller, D.M. 3rd, & Lee, E. (2010) Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α. *Nature Chemical Biology*, Vol.6, No.11, (November 2010), pp. 829–836, ISSN 1552-

endothelial growth factor expression with tumour angiogenesis and early relapse in primary breast cancer. *Japanese Journal of Cancer Research*, Vol.85, No.10, (October

&Tsai, J.H. (1997). Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma. *British Journal of Cancer*, Vol.76, No.2, (June 1997), pp. 244–250 ISSN

adhesion molecule uvomorulin. *Cell Differentiation*, Vol.15, No.2-4, (December

signaling pathways in hepatocellular carcinoma. *Seminars in Liver Disease*, Vol.27,

regulation. *The Journal of Biological Chemistry*, Vol.276, No.17, (April 2001), pp.

Nerve Growth Factor (NGF) involvement in liver cirrhosis and hepatocellular carcinoma. *World Journal of Gastroenterology*, Vol.13, No.37, (October 2007), pp. 4986- 4995, ISSN 1007-9327


Revoltella, R.P. & Butler, R.H. (1980). Nerve growth factor may stimulate either division or

*of Cellular Physiology*, Vol.104, No.1, (July 1980), pp. 27-33, ISSN0021-9541 Rosato, A., Banzato, A., De Luca, G., Renier, D., Bettella, F., Pagano, C., Esposito, G.,

Sapra, P. & Allen, T. M. (2003). Ligand-targeted liposomal anticancer drugs. *Progress in Lipid Research*, Vol.42, No.5, (September 2003), pp. 439-462, ISSN 0163-7827 Sato, Y., Nakata, K., Kato, Y., et al. (1993). Early recognition of hepatocellular carcinoma

Seiter, S., Schadendorf, D., Herrmann, K., Schneider, M., Rosel, M., Arch, R. Tilgen, W. &

Semela, D. & Dufour JF. (2004). Angiogenesis and hepatocellular carcinoma. *Journal of Hepatology*, Vol.41, No.5, (November 2004), pp. 864–880, ISSN 0168-8278 Serafino, A., Zonfrillo, M., Andreola, F., Psaila, R., Mercuri, L., Moroni, N., Renier, D.,

Shan, J., Shi, D.L., Wang, J. & Zheng, J. (2005). Identification of a specific inhibitor of the

Sherlock, S. & Dooley, J. (2002). Malignant liver tumors, In: *Diseases of the Liver and Biliary* 

Shiozaki, H., Oka, H., Inoue, M., Tamura, S. & Monden, M. (1996). E-cadherin mediated

Sofroniew, M.V., Howe, C.L. & Mobley, W.C. (2001). Nerve growth factor signaling,

Sortino, M.A., Condorelli, F., Vancheri, C., Chiarenza, A., Bernardini, R., Consoli, U. &

*Oncology*, Vol.24, No.3, (June 2006), pp. 207-215, ISSN 1078-1439

Vol.328, No.25, (June 1993), pp. 1802–1806, ISSN 0028-4793

4995, ISSN 1007-9327

9139

2011), pp. 572-585, ISSN1568-0096

ISBN 0-632-05582-0, Oxford, UK

2001), pp. 1217-1281, ISSN 0147-006X

15503, ISSN 0006-2960

1613, ISSN 0008-543X

Nerve Growth Factor (NGF) involvement in liver cirrhosis and hepatocellular carcinoma. *World Journal of Gastroenterology*, Vol.13, No.37, (October 2007), pp. 4986-

differentiation of cloned C1300 neuroblastoma cells in serum-free cultures. *Journal* 

Zanovello, P. & Bassi, P. (2006). HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer. *Urologic*

based on altered profiles of alpha-fetoprotein. *The New England Journal of Medicine*,

Zöller, M. (1996) Expression of CD44 variant isoforms in malignant melanoma. *Clinical Cancer Research*, Vol.2, No.3, (March 1996), pp. 447–456, ISSN 1078-0432 Seitz, H.K. & Becker, P. (2007). Alcohol metabolism and cancer risk. *Alcohol Research & Health*, Vol.30, No.1, (December 2007), pp. 38-41 44-47, ISSN 1535-7414 Sekine, S., Lan, B.Y., Bedolli, M., Feng, S. & Hebrok, M. (2006). Liver-specific loss of β-

catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice. *Hepatology*, Vol.43, No.4, (April 2006), pp. 817–825, ISSN 0270-

Campisi, M., Secchieri, C. & Pierimarchi, P. CD44-Targeting for Antitumor Drug Delivery: a New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis. (2011). *Current Cancer Drug Targets*, Vol.11, No.5, (June

dishevelled PDZ domain. *Biochemistry*, Vol.44, No.47, (November 2005), pp. 15495–

*System*, S. Sherlock & J. Dooley (eds.), pp. 537-562, Blackwell Publishing Company

adhesion system in cancer cells. *Cancer*, Vol.77, No.8 Suppl, (April 1996), pp. 1605–

neuroprotection, and neural repair. *Annual Review of Neuroscience*, Vol.24, (March

Canonico, P.L. (2000). Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors. *Molecular Endocrinol*ogy, Vol.14, No, (January 2000), pp, 124-136, ISSN 0888-8809


**Part 2** 

**Carcinogenesis / Invasion / Metastasis** 

